Japan Suspends 1.6 Million Doses of the Moderna Vax
By Vince Quill
Of course they did, right?
These ‘vaccines’ were rushed to market in a way I have never seen in my lifetime.
Why were they rushed?
Cowardice. Plain and simple.
If the general public in most countries did not consist of cowards, the MSM, and the multi-national drug conglomerates would never have been able to force people into a frenzied panic over a virus that has less than a 1% fatality rate.
The rushed ‘vaccines’ came because cowards screeched and demanded them to be rushed, and now here we are 8 months later and the effects of putting fear over logic are apparent for all to see.
Japan became the latest country to suspend at least some vaccines for safety issues:
The suspension of some Moderna doses was due to foreign contamination according to The Epoch Times:
Takeda Pharmaceutical, a Japanese drugmaker distributing the Moderna vaccines in Japan, had received reports of contamination from multiple vaccination sites. The health ministry subsequently learned about the matter on Aug. 25, reported the outlet.
A ministry official was reported by Nikkei Asia as saying, “It’s a substance that reacts to magnets … it could be metal.”
The reports of contamination involve a batch that has a total of 565,400 doses. The ministry said that it decided to suspend the lot as a precaution after it consulted with Takeda. It also suspended another two batches.The three batches altogether contain 1.63 million vaccine doses, which have been distributed to 863 vaccination centers across the country. The ministry will request the centers not to use them.
The health ministry and Takeda did not give details on the type of contamination or if the doses in question may have been distributed outside Japan.
The Moderna vaccine problem came just as Japan struggles with surging infections, with daily new cases hitting new highs in many parts of the country and severely straining the health care system.
Japan relies entirely on foreign-developed vaccines by Moderna, as well as Pfizer Inc. and AstraZeneca. Moderna has been since mid-June at large-scale centers and workplace inoculations and has helped speed up Japan’s rollout.